Timing of Onset of Adverse Events With Setmelanotide, an MC4R Agonist, in Patients With Severe Obesity Due to LEPR or POMC Deficiency

Introduction: Setmelanotide is a melanocortin 4 receptor agonist indicated for chronic weight management in patients with obesity due to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency. This analysis aimed to assess the timing o...

Descripción completa

Detalles Bibliográficos
Autores principales: Clément, Karine, van den Akker, Erica L T, Gordon, Gregory, Yuan, Guojun, Kühnen, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Adipose Tissue, Appetite, and Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265764/
http://dx.doi.org/10.1210/jendso/bvab048.058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265764/
http://dx.doi.org/10.1210/jendso/bvab048.058

Ejemplares similares